MethylScan HCC
Use
MethylScan™ HCC analyzes DNA methylation patterns in cell-free DNA (cfDNA) circulating in the bloodstream, offering an assessment of liver health. It is specifically used to detect hepatocellular carcinoma (HCC) at early stages in individuals at risk, which includes people with cirrhosis and chronic hepatitis B. The test adds sensitivity and specificity to traditional surveillance methods such as ultrasound and AFP, aiming to improve early detection of HCC.
Special Instructions
Not provided.
Limitations
The MethylScan™ HCC test should complement, not replace, standard HCC surveillance methods which include semi-annual AFP blood tests and ultrasounds. However, the MethylScan has potential limitations in cases where methylation patterns in cfDNA may not reflect the presence or stage of HCC accurately, emphasizing the need for comprehensive patient assessment and follow-up.
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
cfDNA Methylation Patterns
Signature
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
A single blood draw is required for analysis. The request for a blood collection kit can be made via email at [email protected].